# Multimodal Model Predicts Treatment Efficacy and CIP Risk in Advanced NSCLC With Immunotherapy and Chemotherapy

> **NCT07243899** · — · COMPLETED · sponsor: **Shanghai Zhongshan Hospital** · enrollment: 3000 (actual)

## Conditions studied

- NSCLC

## Interventions

- **OTHER:** This study is an observational study; the intervention is not applicable.

## Key facts

- **NCT ID:** NCT07243899
- **Lead sponsor:** Shanghai Zhongshan Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-01
- **Primary completion:** 2025-02-28
- **Final completion:** 2025-08-31
- **Target enrollment:** 3000 (ACTUAL)
- **Last updated:** 2025-11-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07243899

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07243899, "Multimodal Model Predicts Treatment Efficacy and CIP Risk in Advanced NSCLC With Immunotherapy and Chemotherapy". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT07243899. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*